ArticleFrontiers in robotics and AI2026
Workspace and trajectory-based experimental validation of a 3-armed 6-DOF parallel robot for femoral fracture surgery.
Article in Frontiers in robotics and AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Femur fractures remain a significant occurrence in the general population, requiring immediate medical care (typically surgery) followed by extensive recovery time. Femur fracture reduction, defined as the process of realigning femur bone fragments, is currently performed manually, a task that is physically demanding and associated with high malalignment rates. Our surgical system Robossis, a 3-armed, 6-DOF parallel robot, is aimed at addressing these issues by exerting the necessary forces to eliminate the physical demand while facilitating proper fracture reduction. The new Robossis V2 system demonstrates improvements over our previous V1 system in both clinical usability and movement capabilities. In this work, we present an experimental validation of Robossis V2 through numerical workspace analysis and optical-tracking-based trajectory testing. Workspace evaluation shows that Robossis V2 provides substantial coverage beyond clinically required alignment ranges, with constrained translational and rotational workspace volumes approximately 136 times and 79 times larger than the required range, respectively. Across all collected trajectory data, Robossis V2 achieved consistent sub-millimeter translational and sub-degree rotational performance, with the 75th percentile of absolute errors remaining below 1 mm and 1
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.